We read with interest the article, “Toxicity of Antihypertensives in Unintentional Poisoning of Young Children” by Hetterich et al. (1). While we agree that poison centers should be consulted after pediatric exposures to antihypertensives, we have concerns about the conclusion that calcium channel antagonists (CCAs) do not share the same level of consideration as moxonidine and clonidine. With respect to the presented data, the authors mistakenly equate “potential exposures” with “poisonings,” as there is no description of how they concretely concluded that each exposure actually occurred, either via history (witnessed ingestion, etc.) or laboratory confirmation....
Language: en
", language="en", issn="0736-4679", doi="10.1016/j.jemermed.2014.09.070", url="http://dx.doi.org/10.1016/j.jemermed.2014.09.070" }